Filing Details

Accession Number:
0001127602-18-001866
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-16 17:20:45
Reporting Period:
2018-01-12
Accepted Time:
2018-01-16 17:20:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711404 Cooper Companies Inc COO Ophthalmic Goods (3851) 942657368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182773 E Allan Rubenstein 6140 Stoneridge Mall Drive
Suite 590
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-12 3,060 $162.69 8,628 No 4 M Direct
Common Stock Acquisiton 2018-01-12 3,390 $154.77 12,018 No 4 M Direct
Common Stock Disposition 2018-01-12 3,225 $227.57 8,793 No 4 S Direct
Common Stock Disposition 2018-01-12 3,225 $230.00 5,568 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-employee Director Stock Option (Right to Buy) Disposition 2018-01-12 3,060 $0.00 3,060 $162.69
Common Stock Non-employee Director Stock Option (Right to Buy) Disposition 2018-01-12 3,390 $0.00 3,390 $154.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-11-03 2024-11-02 No 4 M Direct
0 2016-11-02 2025-11-01 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.411 to $227.599. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.